AVR Stock: Price, Forecast, Financials & AI Analysis

Loading...

High

6.620

Open

4.990

VWAP

5.75

Vol

5.80M

Mkt Cap

236.89M

Low

4.880

Amount

33.35M

EV/EBITDA(TTM)

--

Total Shares

41.20M

EV

196.28M

EV/OCF(TTM)

--

P/S(TTM)

86.04

Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.

Show More

Events Timeline

(ET)

2026-01-20

16:10:00

Anteris Technologies Plans $200M Public Offering

2026-01-02 (ET)

2026-01-02

17:30:00

Anteris Technologies Files $500M Mixed Securities Shelf

2025-11-17 (ET)

2025-11-17

06:08:27

Anteris Technologies Showcases Data from 100 Patients with DurAVR(R) THV at PCR London

2025-11-03 (ET)

2025-11-03

07:17:21

Anteris Technologies granted FDA approval to start PARADIGM trial

2025-10-28 (ET)

2025-10-28

18:18:33

Anteris Technologies shares clinical results for DurAVR THV in patients

2025-10-27 (ET)

2025-10-27

17:47:18

Anteris Technologies administers treatment to first patient in pivotal trial for DurAVR heart valve

2025-10-15 (ET)

2025-10-15

09:22:32

Anteris Secures Initial European Approval to Launch DurAVR Trial

News

an image of NASDAQ.COM

07:04 AMNASDAQ.COM

Anteris Technologies Prices 34.78M Share Offering at $5.75, Raising $200M

an image of Benzinga

07:03 AMBenzinga

Anteris Technologies (AVR) Announces $200 Million Capital Raise, Shares Surge 52.17%

an image of seekingalpha

06:11 AMseekingalpha

Anteris Technologies (AMEUF) Prices Public Offering of 34.78M Shares at $5.75, Raising Approximately $200M

an image of Globenewswire

04:47 AMGlobenewswire

Anteris Technologies Prices Public Offering of 34.78 Million Shares at $5.75 Each, Raising Approximately $200 Million

an image of Newsfilter

04:42 AMNewsfilter

Anteris Technologies Prices Public Offering of 34.78 Million Shares at $5.75, Expected to Raise $200 Million

an image of moomoo

ANTERIS TECHNOLOGIES GLOBAL CORP ANNOUNCES OFFERING PRICING

3 Analyst Rating

Wall Street analysts forecast AVR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVR is 19.00 USD with a low forecast of 15.00 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

0 Hold

0 Sell

Strong Buy

Current: 0.000

Low

15.00

Averages

19.00

High

22.00

Current: 0.000

Low

15.00

Averages

19.00

High

22.00

an image of No data

No data

Valuation Metrics

The current forward P/E ratio for Anteris Technologies Global Corp (AVR.O) is -2.31, compared to its 5-year average forward P/E of -2.31. For a more detailed relative valuation and DCF analysis to assess Anteris Technologies Global Corp 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

an image of dotted line Image

N/A

5Y Average PE

-2.31

Current PE

-2.31

Overvalued PE

-1.58

Undervalued PE

-3.05

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

an image of dotted line Image

N/A

5Y Average EV/EBITDA

-1.72

Current EV/EBITDA

-2.17

Overvalued EV/EBITDA

-0.83

Undervalued EV/EBITDA

-2.60

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

an image of dotted line Image

5Y Average PS

35.41

Current PS

26.18

Overvalued PS

56.43

Undervalued PS

14.39

Financials

Al Analysis

Annual

Quarterly

Trading Trends

People Also Watch

Frequently Asked Questions

What is Anteris Technologies Global Corp (AVR) stock price today?

The current price of AVR is 5.75 USD — it has increased 12.52 % in the last trading day.

What is Anteris Technologies Global Corp (AVR)'s business?

Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.

What is the price predicton of AVR Stock?

Wall Street analysts forecast AVR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVR is19.00 USD with a low forecast of 15.00 USD and a high forecast of 22.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Anteris Technologies Global Corp (AVR)'s revenue for the last quarter?

Anteris Technologies Global Corp revenue for the last quarter amounts to 429.00K USD, decreased -44.21 % YoY.

What is Anteris Technologies Global Corp (AVR)'s earnings per share (EPS) for the last quarter?

Anteris Technologies Global Corp. EPS for the last quarter amounts to -0.62 USD, increased 1.64 % YoY.

How many employees does Anteris Technologies Global Corp (AVR). have?

Anteris Technologies Global Corp (AVR) has 136 emplpoyees as of January 21 2026.

What is Anteris Technologies Global Corp (AVR) market cap?

Today AVR has the market capitalization of 236.89M USD.